Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.

Jha S, Fratzl-Zelman N, Roschger P, Papadakis GZ, Cowen EW, Kang H, Lehky TJ, Alter K, Deng Z, Ivovic A, Flynn L, Reynolds JC, Dasgupta A, Miettinen M, Lange E, Katz J, Klaushofer K, Marini JC, Siegel RM, Bhattacharyya T.

J Bone Miner Res. 2019 Jan;34(1):145-156. doi: 10.1002/jbmr.3577. Epub 2018 Sep 14.

PMID:
30138550
2.

Electrical impedance myography in individuals with collagen 6 and laminin α-2 congenital muscular dystrophy: a cross-sectional and 2-year analysis.

Nichols C, Jain MS, Meilleur KG, Wu T, Collins J, Waite MR, Dastgir J, Salman A, Donkervoort S, Duong T, Keller K, Leach ME, Lott DJ, McGuire MN, Nelson L, Rutkowski A, Vuillerot C, Bönnemann CG, Lehky TJ.

Muscle Nerve. 2018 Jan;57(1):54-60. doi: 10.1002/mus.25629. Epub 2017 Apr 25.

3.

Neurologic involvement in patients with atypical Chediak-Higashi disease.

Introne WJ, Westbroek W, Groden CA, Bhambhani V, Golas GA, Baker EH, Lehky TJ, Snow J, Ziegler SG, Malicdan MC, Adams DR, Dorward HM, Hess RA, Huizing M, Gahl WA, Toro C.

Neurology. 2017 Feb 14;88(7):e57-e65. doi: 10.1212/WNL.0000000000003622.

4.

Peripheral nervous system manifestations of Chediak-Higashi disease.

Lehky TJ, Groden C, Lear B, Toro C, Introne WJ.

Muscle Nerve. 2017 Mar;55(3):359-365. doi: 10.1002/mus.25259. Epub 2016 Dec 16.

5.

Neurologic involvement in patients with atypical Chediak-Higashi disease.

Introne WJ, Westbroek W, Cullinane AR, Groden CA, Bhambhani V, Golas GA, Baker EH, Lehky TJ, Snow J, Ziegler SG, Adams DR, Dorward HM, Hess RA, Huizing M, Gahl WA, Toro C.

Neurology. 2016 Apr 5;86(14):1320-1328. doi: 10.1212/WNL.0000000000002551. Epub 2016 Mar 4. Erratum in: Neurology. 2017 Feb 14;88(7):720. Neurology. 2017 Feb 14;88(7):721. Corrected and republished in: Neurology. 2017 Feb 14;88(7):e57-e65.

6.

Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype.

Schanz O, Bageac D, Braun L, Traynor BJ, Lehky TJ, Floeter MK.

Muscle Nerve. 2016 Aug;54(2):264-9. doi: 10.1002/mus.25047. Epub 2016 May 25.

7.

Electrical impedance myography discriminates congenital muscular dystrophy from controls.

Schwartz DP, Dastgir J, Salman A, Lear B, Bönnemann CG, Lehky TJ.

Muscle Nerve. 2016 Mar;53(3):402-6. doi: 10.1002/mus.24770. Epub 2015 Aug 13.

PMID:
26179210
8.

Peripheral neuropathy in a family with Sandhoff disease and SH3TC2 deficiency.

Grunseich C, Schindler AB, Chen KL, Bakar D, Mankodi A, Traslavina R, Ray-Chaudhury A, Lehky TJ, Baker EH, Maragakis NJ, Tifft CJ, Fischbeck KH.

J Neurol. 2015;262(4):1066-8. doi: 10.1007/s00415-015-7683-x. Epub 2015 Mar 4. No abstract available.

9.

Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat.

Grunseich C, Kats IR, Bott LC, Rinaldi C, Kokkinis A, Fox D, Chen KL, Schindler AB, Mankodi AK, Shrader JA, Schwartz DP, Lehky TJ, Liu CY, Fischbeck KH.

Neuromuscul Disord. 2014 Nov;24(11):978-81. doi: 10.1016/j.nmd.2014.06.441. Epub 2014 Jul 3.

10.

Novel SNP array analysis and exome sequencing detect a homozygous exon 7 deletion of MEGF10 causing early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).

Pierson TM, Markello T, Accardi J, Wolfe L, Adams D, Sincan M, Tarazi NM, Fajardo KF, Cherukuri PF, Bajraktari I, Meilleur KG, Donkervoort S, Jain M, Hu Y, Lehky TJ, Cruz P, Mullikin JC, Bonnemann C, Gahl WA, Boerkoel CF, Tifft CJ.

Neuromuscul Disord. 2013 Jun;23(6):483-8. doi: 10.1016/j.nmd.2013.01.013. Epub 2013 Mar 1.

11.

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

Wang XM, Lehky TJ, Brell JM, Dorsey SG.

Cytokine. 2012 Jul;59(1):3-9. doi: 10.1016/j.cyto.2012.03.027. Epub 2012 Apr 24. Review.

12.

Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.

Lehky TJ, Iwamoto FM, Kreisl TN, Floeter MK, Fine HA.

Neurology. 2011 Jan 18;76(3):236-41. doi: 10.1212/WNL.0b013e3182074a69.

13.

Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.

Fernández-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, Jeffries NO, Shrader JA, Lehky TJ, Li L, Ryder JE, Levy EW, Solomon BI, Harris-Love MO, La Pean A, Schindler AB, Chen C, Di Prospero NA, Fischbeck KH.

Lancet Neurol. 2011 Feb;10(2):140-7. doi: 10.1016/S1474-4422(10)70321-5. Epub 2011 Jan 6.

14.

Unrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings.

Cable C, Finkel RS, Lehky TJ, Biassou NM, Wiggs EA, Bunin N, Pierson TM.

Mol Genet Metab. 2011 Feb;102(2):207-9. doi: 10.1016/j.ymgme.2010.10.002. Epub 2010 Oct 28.

15.

Clinical features of spinal and bulbar muscular atrophy.

Rhodes LE, Freeman BK, Auh S, Kokkinis AD, La Pean A, Chen C, Lehky TJ, Shrader JA, Levy EW, Harris-Love M, Di Prospero NA, Fischbeck KH.

Brain. 2009 Dec;132(Pt 12):3242-51. doi: 10.1093/brain/awp258.

16.

Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophy.

Lehky TJ, Chen CJ, di Prospero NA, Rhodes LE, Fischbeck K, Floeter MK.

Muscle Nerve. 2009 Nov;40(5):809-14. doi: 10.1002/mus.21399.

17.

Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.

Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK.

Muscle Nerve. 2004 Mar;29(3):387-92.

PMID:
14981738
18.

HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease.

Soldan SS, Graf MD, Waziri A, Flerlage AN, Robinson SM, Kawanishi T, Leist TP, Lehky TJ, Levin MC, Jacobson S.

J Infect Dis. 1999 Sep;180(3):685-94.

PMID:
10438355
19.

Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.

Lehky TJ, Levin MC, Kubota R, Bamford RN, Flerlage AN, Soldan SS, Leist TP, Xavier A, White JD, Brown M, Fleisher TA, Top LE, Light S, McFarland HF, Waldmann TA, Jacobson S.

Ann Neurol. 1998 Dec;44(6):942-7.

PMID:
9851439
20.

Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease.

Levin MC, Lehky TJ, Flerlage AN, Katz D, Kingma DW, Jaffe ES, Heiss JD, Patronas N, McFarland HF, Jacobson S.

N Engl J Med. 1997 Mar 20;336(12):839-45. No abstract available.

22.

Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles.

Lehky TJ, Flerlage N, Katz D, Houff S, Hall WH, Ishii K, Monken C, Dhib-Jalbut S, McFarland HF, Jacobson S.

Ann Neurol. 1996 Nov;40(5):714-23.

PMID:
8957012
23.

Induction of HLA class II in HTLV-I infected neuronal cell lines.

Lehky TJ, Jacobson S.

J Neurovirol. 1995 Jun;1(2):145-56.

PMID:
9222353
24.

Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization.

Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, Sato E, Raine CS, Osame M, Jacobson S.

Ann Neurol. 1995 Feb;37(2):167-75.

PMID:
7847858
25.

In situ PCR for the detection of HTLV-I in HAM/TSP patients.

Walter MJ, Lehky TJ, Fox CH, Jacobson S.

Ann N Y Acad Sci. 1994 Jun 6;724:404-13. Review. No abstract available.

PMID:
8030966
26.
27.

Myelin basic protein-specific T cell lines and clones derived from SJL/J mice with experimental allergic encephalomyelitis.

Richert JR, Lehky TJ, Muehl LA, Mingioli ES, McFarlin DE.

J Neuroimmunol. 1985 May;8(2-3):129-39.

PMID:
2581993

Supplemental Content

Loading ...
Support Center